Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-3635
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy ; volume:5 ; number:1 ; day:18 ; month:12 ; year:2020 ; pages:1-29 ; date:12.2020
Signal transduction and targeted therapy ; 5, Heft 1 (18.12.2020), 1-29, 12.2020
- Urheber
-
Carter, Jenna L.
Hege, Katie
Yang, Jay
Kalpage, Hasini A.
Su, Yongwei
Edwards, Holly
Hüttemann, Maik
Taub, Jeffrey W.
Ge, Yubin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41392-020-00361-x
- URN
-
urn:nbn:de:101:1-2021011519002069324905
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carter, Jenna L.
- Hege, Katie
- Yang, Jay
- Kalpage, Hasini A.
- Su, Yongwei
- Edwards, Holly
- Hüttemann, Maik
- Taub, Jeffrey W.
- Ge, Yubin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting acute myeloid leukemia stem cell signaling by natural products
Molecular targeting in acute myeloid leukemia
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia
Targeting the mitochondria in acute myeloid leukemia
Targeting CD33 for acute myeloid leukemia therapy
Targeting self-renewal pathways in myeloid malignancies
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
Targeting CLL-1 for acute myeloid leukemia therapy
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Targeting MAPK pathways in mast cell leukemia
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
Targeting acute myeloid leukemia stem cell signaling by natural products
Molecular targeting in acute myeloid leukemia
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia
Targeting the mitochondria in acute myeloid leukemia
Targeting CD33 for acute myeloid leukemia therapy
Targeting self-renewal pathways in myeloid malignancies
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
Targeting CLL-1 for acute myeloid leukemia therapy
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Targeting MAPK pathways in mast cell leukemia
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
Targeting acute myeloid leukemia stem cell signaling by natural products
Molecular targeting in acute myeloid leukemia
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia
Targeting the mitochondria in acute myeloid leukemia
Targeting CD33 for acute myeloid leukemia therapy
Targeting self-renewal pathways in myeloid malignancies
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
Targeting CLL-1 for acute myeloid leukemia therapy
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Targeting MAPK pathways in mast cell leukemia